Claims for Patent: 7,125,666

Summary for Patent: 7,125,666

Title:	Collagen XXII, a novel human collagen and uses thereof
Abstract:	The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
Inventor(s):	Burgeson; Robert Eugene (Palm Springs, CA), Koch; Manuel (Cambridge, MA), Keene; Douglas R. (Portland, OR), Brunken; William Joseph (Canton, MA), Bruckner-Tuderman; Leena (Munster, DE)
Assignee:	The General Hospital Corporation (Boston, MA)
Application Number:	10/202,167
Patent Claims:	1. An isolated nucleic acid molecule comprising a nucleotide sequence that is at least 80% identical to the nucleotide sequence of SEQ ID NO:3. 2. The nucleic acid of claim 1, wherein the nucleotide sequence is at least 85% identical to the nucleotide sequence of SEQ ID NO:3. 3. The nucleic acid of claim 1, wherein the nucleotide sequence is at least 90% identical to the nucleotide sequence of SEQ ID NO:3. 4. The nucleic acid of claim 1, wherein the nucleotide sequence is at least 95% identical to the nucleotide sequence of SEQ ID NO:3. 5. The nucleic acid of claim 1, wherein the nucleotide sequence is at least 98% identical to the nucleotide sequence of SEQ ID NO:3. 6. The nucleic acid of claim 1, wherein the nucleotide sequence is identical to the nucleotide sequence of SEQ ID NO:3. 7. A nucleic acid comprising a nucleotide sequence at least 85% identical to an alternatively spliced variant of SEQ ID NO:1 or SEQ ID NO:3, which variant lacks the sequence corresponding to nucleotides 3458 3518 of SEQ ID NO:1. 8. An isolated nucleic acid consisting of the sequence of SEQ ID NO:1 or SEQ ID NO:3 and its complement. 9. An isolated nucleic acid that encodes a polypeptide having an amino acid sequence which is at least 80% identical to the amino acid sequence of SEQ ID NO:2. 10. The nucleic acid of claim 9, wherein the polypeptide has an amino acid sequence at least 85% identical to the amino acid sequence of SEQ ID NO:2. 11. The nucleic acid of claim 9, wherein the polypeptide has an amino acid sequence at least 90% identical to the amino acid sequence of SEQ ID NO:2. 12. The nucleic acid of claim 9, wherein the polypeptide has an amino acid sequence at least 95% identical to the amino acid sequence of SEQ ID NO:2. 13. The nucleic acid of claim 9, wherein the polypeptide has an amino acid sequence-identical to the amino acid sequence of SEQ ID NO:2. 14. The nucleic acid of claim 9, wherein the polypeptide has one or more of the following activities: (a) has the ability to form a triple helix; (b) has the ability to form collagen fibrils or fibers; (c) localizes to muscle-connective tissue boundaries; (d) binds specifically to an antibody that binds to a polypeptide consisting of residues 28 1626 of SEQ ID NO:2; and (e) is collagenase sensitive. 15. An isolated nucleic acid that encodes a polypeptide comprising one or more of: residues 1 27 of SEQ ID NO:2; residues 28 1478 of SEQ ID NO:2; residues 1479 1603 of SEQ ID NO:2; and residues 1604 1626 of SEQ ID NO:2. 16. An isolated nucleic acid comprising a nucleotide sequence more than 500 nucleotides in length that hybridizes under highly stringent conditions, comprising 6.times.SSC at 45.degree. C., followed by one wash in 0.2.times.SSC, 0.1% SDS at 65.degree. C., to a nucleotide sequence consisting of SEQ ID NO:1 or 3, or the complement of SEQ ID NO:1 or 3, wherein the nucleic acid encodes a polypeptide comprising one or more of the following activities: (a) has the ability to form a triple helix; (b) has the ability to form collagen fibrils or fibers; (c) localizes to muscle-connective tissue boundaries; (d) binds specifically to an antibody that binds to a polypeptide consisting of residues 28 1626 of SEQ ID NO: 2; and (e) is collagenase sensitive. 17. An isolated nucleic acid comprising a nucleotide sequence more than 500 nucleotides in length that hybridizes under highly stringent conditions, comprising 6.times.SSC at 45.degree. C., followed by one wash in 0.2.times.SSC, 0.1% SDS at 65.degree. C., to a nucleotide sequence that encodes a polypeptide having the amino acid sequence of SEQ ID NO:2, or its complement. 18. The nucleic acid of claim 17, wherein the nucleic acid encodes a polypeptide comprising one or more of the following activities: (a) has the ability to form a triple helix; (b) has the ability to form collagen fibrils or fibers; (c) localizes to muscle-connective tissue boundaries; (d) binds specifically to an antibody that binds to a polypeptide consisting of residues 28 1626 of SEQ ID NO:2; and (e) is collagenase sensitive. 19. The nucleic acid molecule of any one of claims 1, 6, 9, 13 or 16 further comprising a nucleic acid sequence encoding an amino acid sequence that is heterologous to SEQ ID NO:2. 20. A vector comprising the nucleic acid molecule of any one of claims 1, 6, 9, 13, or 16. 21. An isolated host cell harboring the vector of claim 20. 22. The host cell of claim 21, wherein the host cell is a mammalian cell. 23. The nucleic acid of claim 16 or 17, wherein the nucleic acid is at least 95% identical to SEQ ID NO:3. 24. An isolated probe or primer that hybridizes under highly stringent conditions, comprising 6.times.SSC at 45.degree. C., followed by one wash in 0.2.times.SSC, 0.1% SDS at 65.degree. C., to the sense or antisense nucleic acid sequence of SEQ ID NO:1 or SEQ ID NO:3, wherein the isolated probe or primer is between 50 and 300 nucleotides in length. 25. A method for detecting the presence of a nucleic acid molecule in a sample, the method comprising the steps of: a) contacting the sample with the probe of claim 24; and b) determining whether the probe binds to a nucleic acid molecule in the sample. 26. The method of claim 25, wherein the sample comprises mRNA molecules. 27. An isolated nucleic acid that comprises a nucleic acid sequence that encodes a polypeptide comprising an amino acid sequence at least 95% identical to a sequence selected from the group consisting of: (i) residues 1 1004 of SEQ ID NO:2; (ii) residues 28 1478 of SEQ ID NO:2; (iii) residues 1479 1603 of SEQ ID NO:2; (iv) residues 1025 1626 of SEQ ID NO:2; and (v) SEQ ID NO:2 that lacks amino acids 1005 1024. 28. The nucleic acid of claim 27 wherein the polypeptide comprises an amino acid sequence at least 95% identical to (iv) 1025 1626 of SEQ ID NO:2. 29. The nucleic acid of claim 28 wherein the polypeptide comprises residues 1025 1626 of SEQ ID NO:2. 30. The nucleic acid of claim 27 wherein the polypeptide comprises an amino acid sequence at least 95% identical to (ii) residues 28 1478 of SEQ ID NO:2. 31. The nucleic acid of claim 30 wherein the polypeptide comprises residues 28 1478 of SEQ ID NO:2. 32. The nucleic acid of claim 27 wherein the polypeptide further comprises a glutathione-S-transferase (GST) moiety.

Details for Patent 7,125,666

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2021-07-31